Originate in the United States,with years of IHC/ISH Development and production experience,Xiamen Talent Biomedical Technology Co.,Ltd is committing to offer comprehensive IHC/ISH solution covering self-developing and manufacturing IHC detection reagents and kits,instruments.
Why Choose Us
◆ R&D based manufacturer of lHC instruments and reagents
◆ Market leader in China in the fields of lHC
◆ Excellent performance in the fields of In-Situ Hybridization
◆ Jun. 2018 High-throughput automatic stainer and “Grape- cluster” Compact Secondary Antibody were launched
◆ Jan. 2019 Got 19 patents in USA, Canada, Japan, China, etc.,
◆ Jan. 2020 25 kinds of In-Situ Hybridization products were launched (EBER, Kappa, Lambda, ALK, RET，ROS1 etc.,)
NMPA
◆ More than 400 products have NMPA certificates
◆ NMPA is National Medical Products Administration
EBV probe,Epstein-Barr encoding region (EBER) in situ hybridization is the methodology of choice for the detection of the Epstein-Barr virus (EBV) in tissue sections.
Subscribe to our weekly newsletter and receive exclusive offers on products you love!
X
